Dimethyl Fumarate Safe and Effective Over Years of Use in Multiple Sclerosis
Over 5 years, dimethyl fumarate had a favorable safety and efficacy profile in reducing the annualized relapse rate in patients with multiple sclerosis.
Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Over 5 years, dimethyl fumarate had a favorable safety and efficacy profile in reducing the annualized relapse rate in patients with multiple sclerosis.
Features of obesity, like body mass index and visceral adipose tissue, may have a pleiotropic effect on the genetic risk for multiple sclerosis.
Despite sweeping regulatory changes, usage of cannabis by patients with multiple sclerosis remains relatively steady, especially for treating spasticity, new research shows.
Information and support from health care providers for caregivers of people diagnosed with multiple sclerosis and/or Alzheimer disease can help address caregiving challenges.
The Timed 25-Foot Walk test is a clinically, objective useful tool for evaluating multiple sclerosis-related disability in routine clinical practice.